Isolation of bacteriocin-producing Staphylococcus spp. strains from human skin wounds, soft tissue infections and bovine mastitis

• Autorzy: Zalewska M. , Churey J.J. , Worobo R.W. , Milewski S. , Szweda P.
• Języki publikacji: EN

Abstrakty

EN

A collection of 206 Staphylococcus spp. isolates was investigated for their ability to produce compounds exhibiting antistaphylococcal activity. This group included Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus xylosus strains recovered from bovine mastitis (n = 158) and human skin wounds and soft tissues infections (n = 48). Production of substances with antimicrobial activity was observed in six strains. Five of them were recovered from bovine mastitis, and one was isolated from the infected human skin wound. Three of the six antimicrobials produced by the different strains showed substantial loss of antimicrobial activity upon treatment with proteolytic enzymes, which suggests their peptidic structure. Additional studies have shown that one of the putative bacteriocins was efficiently secreted to the liquid medium, facilitating its large-scale production and isolation. The peptide produced by the M2B strain exhibited promising activity; however, against narrow spectrum of Staphylococcus spp. clinical and animal isolates. Growth inhibition was observed only in the case of 13 (including nine S. aureus, three S. xylosus and one S. epidermidis strains) out of 206 strains tested. Important advantage of the produced agent was its high thermal stability. Fifteen minutes of incubation at 90°C did not affect its antimicrobial potential. The highest efficiency of production of the agent was demonstrated in TSB medium after 24 hours at 37°C. The researches revealed that ability to production of bacteriocin among staphylococci is not very common. Only one (S. xylosus strain assigned as M2B) out of 206 strains tested produced satisfactory amounts of antistaphylococcal bacteriocin. In spite of that, we would encourage other researchers for investigation of their collections of Staphylococcus spp. isolates towards selection strains producing antimicrobial agents.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2018
• Tom: 67
• Numer: 2
• Opis fizyczny: p.163-169,fig.,ref.

Twórcy

autor

Zalewska M.

• Department of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology, Gdansk, Poland
• Department of Food Science, Cornell University, Ithaca, USA

autor

Churey J.J.

• New York State Agricultural Experiment Station, Department of Food Science, Cornell University, Geneva, USA

autor

Worobo R.W.

• Department of Food Science, Cornell University, Ithaca, USA

autor

Milewski S.

• Department of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology, Gdansk, Poland

autor

Szweda P.

• Department of Pharmaceutical Technology and Biochemistry, Gdansk University of Technology, Gdansk, Poland

Bibliografia

• Andersson D.I., D. Hughes and J.Z. Kubicek-Sutherland. 2016. Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist. Updat. 26: 43–57.
• Barefoot S.F. and T.R. Klaenhammer. 1983. Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl. Environ. Microbiol. 45: 1808–1815.
• Bastos M.C.F., H. Ceotto, M.L.V. Coelho and J.S. Nascimento. 2009. Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications. Curr. Pharm. Biotechnol. 10: 38–61.
• Braem G., B. Stijlemans, W. Van Haken, S. De Vliegher, L. De Vuyst and F. Leroy. 2014. Antibacterial activities of coagulase-negative staphylococci from bovine teat apex skin and their inhibitory effect on mastitis-related pathogens. J. Appl. Microbiol. 116: 1084–1093.
• Brito M.A.V.P., G.A. Somkuti and J.A. Renye. 2011. Production of antilisterial bacteriocins by staphylococci isolated from bovine milk1. J. Dairy Sci. 94: 1194–1200.
• Di Meo F., G. Fabre, K. Berka, T. Ossman, B. Chantemargue,M. Paloncýová, P. Marquet, M. Otyepka and P. Trouillas. 2016. In silico pharmacology: Drug membrane partitioning and crossing. Pharmacol. Res. 111: 471–486.
• Fleming H.P., J.L. Etchells and R.N. Costilow. 1975. Microbial inhibition by an isolate of Pediococcus from Cucumber Brines 1. Appl. Microbiol. 30: 1040–1042.
• Hewelt-Belka W., J. Nakonieczna, M. Belka, T. Bączek, J. Namieśnik and A. Kot-Wasik. 2016. Untargeted lipidomics reveals differences in the lipid pattern among clinical isolates of Staphylococcus aureus resistant and sensitive to antibiotics. J. Proteome Res. 4: 914–22.
• Jakubczak A., P. Szweda, K. Łukaszewska and J. Kur. 2007. Molecular typing of Staphylococcus aureus isolated from cows with mastitis in the east of Poland on the basis of polymorphism of genes coding protein A and coagulase. Pol. J. Vet. Sci. 10: 199–205.
• Joerger R.D. 2003. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poultry Sci. 82: 640–647.
• Kosikowska P. and A. Lesner. 2016. Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015). Expert Opin. Ther. Pat. 26: 689–702.
• Kot B., M. Piechota, M. Antos-Bielska, E. Zdunek, K.M. Wolska, T. Binek, J. Olszewska, P. Guliński and E.A. Trafny. 2012. Antimicrobial resistance and genotypes of staphylococci from bovine milk and the cowshed environment. Pol. J. Vet. Sci. 15: 741–749.
• Kurlenda J. and M. Grinholc. 2012. Alternative therapies in Staphylococcus aureus diseases. Acta Biochim. Pol. 59: 171–184.
• Lee H., J. Churey and R. Worobo. 2008. Antimicrobial activity of bacterial isolates from different floral sources of honey. Int. J. Food Microbiol. 126: 240–244.
• Malanovic N. and K. Lohner. 2016. Antimicrobial peptides targeting Gram-positive bacteria. Pharmaceuticals (Basel). 9(3). pii: E59. doi: 10.3390/ph9030059.
• Nascimento J.S., H. Ceotto, S.B. Nascimento, M. Giambiagi-Demarval, K.N. Santos and M.C.F. Bastos. 2006. Bacteriocins as alternative agents for control of multiresistant staphylococcal strains. Lett. Appl. Microbiol. 42: 215–221.
• Nes I.F. 2011. History, Current Knowledge, and Future Directions on Bacteriocin Research in Lactic Acid Bacteria. In: Drider D. and S. Rebuffat (eds). Prokaryotic Antimicrobial Peptides. Springer, New York, NY
• Ołdak A. and D. Zielińska. 2017. Bacteriocins from lactic acid bac-teria as an alternative to antibiotics. Post. Hig. Med. Dosw. 71: 328–338.
• Powers J.-P.S. and R.E. Hancock. 2003. The relationship between peptide structure and antibacterial activity. Peptides 24: 1681–1691.
• Rashid R., M. Veleba and K.A. Kline. 2016. Focal targeting of the bacterial envelope by antimicrobial peptides. Front. Cell Dev. Biol. 4:55. doi: 10.3389/fcell.2016.00055.
• Schillinger U. and F.K. Lücke. 1989. Antibacterial activity of Lactobacillus sake isolated from meat. Appl. Environ. Microbiol. 55: 1901–1906.
• Sjölund M. and G. Kahlmeter. 2008. Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand. J. Inf. Dis. 40: 894–898.
• Szweda P., M. Schielmann, A. Frankowska, B. Kot and M. Zalewska. 2014. Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B. J. Vet. Med. Sci. 76:355–362.
• Varella Coelho M.L., J.D. Santos Nascimento, P.C. Fagundes,D.J. Madureira, S.S Oliveira, M.A. Vasconcelos de Paiva Brito and C. Freire Bastos Mdo. 2007. Activity of staphylococcal bacteriocins against Staphylococcus aureus and Streptococcus agalactiae involved in bovine mastitis. Res. Microbiol. 158: 625–630.
• Weisburg W.G., S.M. Barns, D.A. Pelletier and D.J. Lane. 1991. 16S ribosomal DNA ampigication for phylogenetic study. J. Bacteriol. 173: 697–703.
• Yeaman, M.R. and N.Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55: 27–55.

Identyfikatory

DOI

10.21307/pjm-2018-018